About Medical Oncology Care Associates
Clinical Trials at Medical Oncology Care Associates
During the past decade, Medical Oncology Care Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on
average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medical Oncology Care Associates" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Sanofi" with 3 trials
sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "CTI BioPharma"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Care Associates"
#1 collaborator was "AbbVie" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Medical Oncology Care Associates
According to Clinical.Site data, the most researched conditions in "Medical Oncology Care Associates" are
"Carcinoma, Non-Small-Cell Lung" (3 trials), "Multiple Myeloma" (3 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Medical Oncology Care Associates" in a lesser frequency.
Clinical Trials Intervention Types at Medical Oncology Care Associates
Most popular intervention types in "Medical Oncology Care Associates" are "Drug" (18 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (3 trials), "Bortezomib" (2 trials), "oxaliplatin" (2 trials), "paclitaxel" (2 trials) and "Avelumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical Oncology Care Associates
The vast majority of trials in "Medical Oncology Care Associates" are
13 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Medical Oncology Care Associates
Currently, there are NaN active trials in "Medical Oncology Care Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Medical Oncology Care Associates,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Medical Oncology Care Associates, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".